Target intelligence / Profile preview

Androctonus amoreuxi venom (A. amoreuxi venom)

Target
A. amoreuxi venom
Molecular classification
Venom, Neurotoxin, Peptide, Ion channel modulator
01

Overview

Androctonus amoreuxi venom is a potent biological secretion from the North African and Middle Eastern scorpion species Androctonus amoreuxi. It contains a diverse array of bioactive peptides, most notably long-chain neurotoxins that selectively bind to and modulate the activity of voltage-gated sodium (Nav) and potassium (Kv) channels in excitable tissues [1][2]. These interactions disrupt normal nerve impulse transmission, leading to the clinical manifestations of scorpionism, such as intense localized pain, autonomic nervous system dysfunction, and potentially lethal cardiovascular or respiratory complications [3]. In the pharmaceutical industry, the venom is studied as a rich source of highly specific ligands for ion channels, which serve as leads for developing novel therapeutics for pain management and neurological disorders [2]. Therapeutic intervention for envenomation relies on the use of antivenoms, which are purified antibodies that sequester and neutralize the venom's toxic components [4]. Beyond its toxicity, the venom serves as a valuable tool in neurobiology for characterizing the structure and function of ion channels [2].

Other names
Egyptian scorpion venomAfrican fat-tailed scorpion venomA. amoreuxi venom
02

Mechanism of action

Neutralization of venom components by specific antibodies (antivenom) to prevent binding to physiological targets such as voltage-gated ion channels.

03

Biological functions

Ion channel modulationNeurotransmission disruptionProteolysisInduction of autonomic storm
04

Disease associations

Scorpion envenomation (Scorpionism)HypertensionPulmonary edemaCardiac failure
05

Safety considerations

Severe neurotoxicityRespiratory failureCardiovascular collapseAnaphylactic shock (associated with antivenom administration)
06

Interacting drugs

Scorpion antivenom (Polyvalent or Monovalent)

3 more in the full profile.

07

Biomarkers

Venom antigen levels (detected via ELISA)Creatine kinase (CK)Blood glucose levels (hyperglycemia is common in severe stings)Troponin I (indicator of cardiac damage)

Beyond the preview

Go deeper on Androctonus amoreuxi venom (A. amoreuxi venom).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Androctonus amoreuxi venom (A. amoreuxi venom).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call